awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38779091-4F5E544A-619C-4E84-839C-9F3A2077225C
Q38779091-4F5E544A-619C-4E84-839C-9F3A2077225C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38779091-4F5E544A-619C-4E84-839C-9F3A2077225C
Disease activity return after natalizumab cessation in multiple sclerosis.
P2860
Q38779091-4F5E544A-619C-4E84-839C-9F3A2077225C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38779091-4F5E544A-619C-4E84-839C-9F3A2077225C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d772fe48da83b9735e477c2fda6eda906b4d246
P2860
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.